Recent studies have begun to elucidate the mechanisms of utilisation of some human milk oligosaccharides (HMO) components by Bifidobacterium breve. However, this phenomenon is still relatively poorly

NIAID Data Ecosystem60

Milk glycan metabolism by intestinal bifidobacteria: insights from comparative genomics

母乳低聚糖代谢

益生元配方优化

Bifidobacteria are early colonizers of the human neonatal gut and provide multiple health benefits to the infant, including inhibiting the growth of enteropathogens and modulating the immune system. C

Taylor & Francis Group2023-05-16 更新30

Human milk oligosaccharides and infant fecal oligosaccharides

母乳低聚糖代谢

婴幼儿肠道微生物组

In this study, we quantitated the disappearance of intact HMOs and characterized the glycan digestion products in the gut that are produced by the action of microbial enzymes on HMOs and glycoconjugat

NIAID Data Ecosystem70

Bifidobacterium longum subsp. infantis and Bifidbacterium longum subsp. suis Genome sequencing and assembly. Bifidobacterium

婴幼儿肠道微生物组

母乳低聚糖代谢

Here we investigated HMO utilization of bifidobacteria that were recently isolated from stool of six month old Kenyan infants and included species such as Bifidobacterium kashiwanohense, Bifidobacteri

NIAID Data Ecosystem40

GltA N83K mutant from Bifidobacterium infantis JCM 1222 complexed with lacto-N-tetraose

资源简介：

相关数据集